![Per Grufman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Per Grufman
Amministratore Delegato presso BioCrucible Ltd.
Posizioni attive di Per Grufman
Società | Posizione | Inizio | Fine |
---|---|---|---|
BioCrucible Ltd.
![]() BioCrucible Ltd. BiotechnologyHealth Technology Part of Sapphiros, BioCrucible Ltd. is a British company that develops high-performance molecular consumer diagnostics. The company is based in Cambridge, UK. BioCrucible is developing next-generation diagnostics based upon breakthrough advances in biomolecular condensate formation. The company aims to develop proprietary molecular detection technologies deploying ultra-rapid isothermal nucleic acid amplification that enable near-patient and at-home testing for infectious disease or genetic indications. The company was founded in 2018 by Niall Antony Armes. Per Grufman has been the CEO of the company since January 20, 2023. BioCrucible was acquired by Sapphiros on July 21, 2021. | Amministratore Delegato | 20/01/2023 | - |
Storia della carriera di Per Grufman
Precedenti posizioni note di Per Grufman
Società | Posizione | Inizio | Fine |
---|---|---|---|
LumiraDx Ltd. (United Kingdom)
![]() LumiraDx Ltd. (United Kingdom) Medical SpecialtiesHealth Technology LumiraDx Ltd. manufactures develops and supplies analytical measurement systems. The firm offers mission cholesterol meters and single test device, blood glucose monitoring system, i-STAT cartridges and sprint blood count devices. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - | - |
Karolinska Institutet | Direttore/Membro del Consiglio | - | - |
Accuro Immunology AB
![]() Accuro Immunology AB Pharmaceuticals: MajorHealth Technology Accuro Immunology AB develops and manufactures active immunotherapy products. The firm's products help to treat the patients suffering from problems with immune escape/evasion. The company was founded by Peter Gunnar Maurits Wolpert and Elisabeth Wolpert in 1999 and is headquartered in Stockholm, Sweden. | Direttore Tecnico/Scientifico/R&S | - | 27/11/2009 |
Corporate Officer/Principal | 27/11/2009 | - | |
AbSorber AB
![]() AbSorber AB Medical SpecialtiesHealth Technology AbSorber AB develops products for allogeneic transplantation. It offers XM-ONE used for enhanced risk assessment before kidney transplantation. The firm also engages in the development of tools in transplantation. The company was founded by Jan Holgersson and Suchitra Sumitran-Holgersson in 1999 and is headquartered in Stockholm, Sweden. | Direttore Tecnico/Scientifico/R&S | - | 27/11/2009 |
Corporate Officer/Principal | 27/11/2009 | - |
Formazione di Per Grufman
Karolinska Institutet | Doctorate Degree |
University of Stockholm | Graduate Degree |
Statistiche
Distribuzione geografica
Svezia | 5 |
Regno Unito | 3 |
Posizioni
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Settori
Health Technology | 5 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 4 |
---|---|
Accuro Immunology AB
![]() Accuro Immunology AB Pharmaceuticals: MajorHealth Technology Accuro Immunology AB develops and manufactures active immunotherapy products. The firm's products help to treat the patients suffering from problems with immune escape/evasion. The company was founded by Peter Gunnar Maurits Wolpert and Elisabeth Wolpert in 1999 and is headquartered in Stockholm, Sweden. | Health Technology |
AbSorber AB
![]() AbSorber AB Medical SpecialtiesHealth Technology AbSorber AB develops products for allogeneic transplantation. It offers XM-ONE used for enhanced risk assessment before kidney transplantation. The firm also engages in the development of tools in transplantation. The company was founded by Jan Holgersson and Suchitra Sumitran-Holgersson in 1999 and is headquartered in Stockholm, Sweden. | Health Technology |
LumiraDx Ltd. (United Kingdom)
![]() LumiraDx Ltd. (United Kingdom) Medical SpecialtiesHealth Technology LumiraDx Ltd. manufactures develops and supplies analytical measurement systems. The firm offers mission cholesterol meters and single test device, blood glucose monitoring system, i-STAT cartridges and sprint blood count devices. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Health Technology |
BioCrucible Ltd.
![]() BioCrucible Ltd. BiotechnologyHealth Technology Part of Sapphiros, BioCrucible Ltd. is a British company that develops high-performance molecular consumer diagnostics. The company is based in Cambridge, UK. BioCrucible is developing next-generation diagnostics based upon breakthrough advances in biomolecular condensate formation. The company aims to develop proprietary molecular detection technologies deploying ultra-rapid isothermal nucleic acid amplification that enable near-patient and at-home testing for infectious disease or genetic indications. The company was founded in 2018 by Niall Antony Armes. Per Grufman has been the CEO of the company since January 20, 2023. BioCrucible was acquired by Sapphiros on July 21, 2021. | Health Technology |
- Borsa valori
- Insiders
- Per Grufman
- Esperienza